Skip to main content

Table 3 Characteristics, from review of health record, of patients enrolled compared to all eligible patients

From: Strategies for recruitment and retention of underrepresented populations with chronic obstructive pulmonary disease for a clinical trial

 

Enrolled

(n = 192)

Eligible, not enrolled

(n = 90)

P-value

Age, in years, mean (sd)

61.6 (7.6)

65.9 (9.1)

p < .01

Male, % (n/N)

68% (125/192)

71% (63/90)

p = .42

Primary language other than English, % (n/N)

10.7% (18/169)

8.1% (7/86)

p = .52

>  1 hospitalization in 12 months prior to recruitment, % (n/N)

30.2% (58/192)

31.1% (28/90)

p = .88

Uses oxygen at home, % (n/N)

6.3% (12/190)

12.2% (11/90)

p = .09

Prescription for LAMA or LABA+ICS*, % (n/N)

78.7% (151/192)

84.4% (76/90)

p = .25

  1. * LAMA Long-acting muscarinic agent; LABA Long-acting beta-antagonist; ICS Inhaled corticosteroid